Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives - Top-Institutions - MDSpire

Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives

  • By

  • Medha Karnik

  • Preethi G. Anantharaju

  • Arati Sharma

  • Olga Sukocheva

  • Edmund Tse

  • SubbaRao V. Madhunapantula

  • July 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, Los Angeles (UCLA) Health
    University of California, Los Angeles (UCLA) Health

    Los Angeles, California

    Key Differentiators

    • Oncology

  • #2

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, Ohio

    Key Differentiators

    • Oncology

  • #3

    Oregon Health & Science University
    Oregon Health & Science University

    Portland, Oregon

    Key Differentiators

    • Oncology

  • #4

    Yale Cancer Center
    Yale Cancer Center

    New Haven, Connecticut

    Key Differentiators

    • Oncology

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

Original Source(s)

Aurora kinase B as a therapeutic target in HPV-induced cervical cancer: mechanisms and future perspectives

  • by Medha Karnik, Preethi G. Anantharaju, Arati Sharma, Olga Sukocheva, Edmund Tse, SubbaRao V. Madhunapantula

  • July 3, 2026

Related Content

Gamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors

A prediction model for urological tumor metastasis using liquid biopsy-derived biomarkers

A multiscale model reveals how ERK/p38-regulated dormancy shapes tumor-immune dynamics and immunoediting outcomes